← Back to Clinical Trials
Recruiting NCT05876208

NCT05876208 Increased Home-based Physical Therapy Adherence Using BAND Connect's VirtuaCare™ Platform

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05876208
Status Recruiting
Phase
Sponsor University of Cincinnati
Condition Shoulder Injuries
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2022-07-05
Primary Completion 2027-01-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
BAND Connect's VirtuaCare™ platformStandard of Care Physical Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2022-07-05 with a primary completion date of 2027-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to enhance at-home therapy by introducing a new device called the BAND Connect's VirtuaCare™ platform. The study aims to determine whether patients can improve their adherence to at-home exercises using this device. Currently, research indicates that only 35% of patients undergoing physical therapy treatment fully comply with their prescribed plans of care, often neglecting their at-home exercises. To address this issue, a set of smart exercise tools called VirtuaCare™ has been developed. This platform provides patients with instructions on performing at-home exercises and offers real-time biofeedback to help them adjust their form if necessary. The study seeks to evaluate the effectiveness of BAND CVCP in assisting patients and improving their overall success with at-home therapy.

Eligibility Criteria

Inclusion Criteria: * Dr. Brian Grawe will perform surgery, and participants will be undergoing post-operative physical therapy rehabilitation at UC Health. * Primary total shoulder arthroplasty and primary reverse total shoulder arthroplasty or Primary rotator cuff repair * Outpatient physical therapy prescribed by the doctor for post-operative rehabilitation Exclusion Criteria: * Unplanned surgical procedure * Partial shoulder replacement or revision shoulder replacement * Revision rotator cuff repair * Fracture surgeries * Prior surgery within the last 5 years or less than 6 months between surgery on opposite shoulder * Length of stay in hospital greater than 3 days * Comorbidity: Uncontrolled diabetes patients; Diagnosed with cancer in the past 5 years or active disease; Any comorbidity that may impact compliance with the study protocol (completion of standard physical therapy rehabilitation procedures) * Injuries related to workers' compensation * Injuries involved in any pending litigation

Contact & Investigator

Central Contact

Kim Hasselfeld

✉ hasselky@uc.edu

📞 513-558-1933

Principal Investigator

Brian M Grawe, MD

PRINCIPAL INVESTIGATOR

University of Cincinnati

Frequently Asked Questions

Who can join the NCT05876208 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Shoulder Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05876208 currently recruiting?

Yes, NCT05876208 is actively recruiting participants. Contact the research team at hasselky@uc.edu for enrollment information.

Where is the NCT05876208 trial being conducted?

This trial is being conducted at Cincinnati, United States.

Who is sponsoring the NCT05876208 clinical trial?

NCT05876208 is sponsored by University of Cincinnati. The principal investigator is Brian M Grawe, MD at University of Cincinnati. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology